By Bharat Biotech Completes Phase III Trials for Hillchol Oral Cholera Vaccine Targeting Ogawa and Inaba Serotypes
by Mark Chiang Share To
Bharat Biotech’s oral cholera vaccine, Hillchol, has successfully completed Phase III clinical trials, demonstrati…
Bharat Biotech Completes Phase III Trials for Hillchol Oral Cholera Vaccine Targeting Ogawa and Inaba Serotypes
IndiaHub